Your Notifications
All done, no notifications

What is MUTYH-Associated Polyposis?

MUTYH-Associated Polyposis (MAP) is an inherited colorectal polyposis syndrome caused by pathogenic variants in both copies of the MUTYH gene. The condition can lead to multiple adenomatous polyps in the colon and rectum and substantially increases the risk of colorectal cancer. MAP may also involve polyps or cancers in other organs, including the duodenum.

Some individuals may develop colorectal cancer even when they have relatively few colorectal polyps, making appropriate genetic assessment and surveillance important.

What is the Importance of Timely Treatment?

Timely diagnosis and surveillance are important because adenomatous polyps associated with MAP can gradually progress to colorectal cancer. Without appropriate surveillance, the lifetime risk of colorectal cancer can be very high. Regular colonoscopy allows doctors to identify and remove precancerous polyps before they progress. When the number or size of polyps becomes difficult to control endoscopically, colorectal surgery may be considered to reduce cancer risk.

What are the Common Symptoms of MUTYH-Associated Polyposis?

  • Multiple adenomatous colorectal polyps
  • Rectal bleeding or blood in the stool
  • Abdominal pain or discomfort
  • Bloating
  • Changes in bowel habits
  • Diarrhea
  • Iron-deficiency anemia
  • Unexplained weight loss
  • Fatigue related to anemia or cancer
  • Colorectal cancer in some individuals
  • Duodenal or other gastrointestinal polyps

Causes and Risk Factors of MUTYH-Associated Polyposis

Causes

  • MAP occurs because of pathogenic variants in both copies of the MUTYH gene, which repairs oxidative DNA damage. When both copies are affected, DNA repair may become less effective, allowing abnormal cells and adenomatous polyps to develop.
  • MAP is inherited in an autosomal recessive pattern, meaning an affected individual generally inherits one pathogenic MUTYH variant from each parent.

Risk Factors

  • Having pathogenic MUTYH variants in both gene copies
  • Having parents who are carriers of a MUTYH pathogenic variant
  • A family history of MAP or colorectal cancer
  • A personal history of multiple adenomatous colorectal polyps
  • Early-onset colorectal cancer
  • Having a sibling with confirmed MAP

Latest Research and Technologies in the Treatment of MUTYH-Associated Polyposis in India

  • Current management of MAP focuses on genetic diagnosis, regular colonoscopic surveillance, advanced polyp removal, and timely colorectal surgery when endoscopic management is no longer sufficient. Germline genetic testing, including multigene panels, can help distinguish MAP from other hereditary colorectal cancer syndromes. High-quality colonoscopy with polypectomy remains central to cancer prevention, while advanced endoscopic techniques can assist in managing suitable adenomas. For patients with extensive polyposis, minimally invasive colorectal surgery may be considered.

Treatment options for MUTYH-Associated Polyposis

Colonoscopic Surveillance and Polyp Removal: Regular high-quality colonoscopy allows doctors to identify and remove adenomatous polyps before they progress. Surveillance intervals are generally based on individual polyp burden and clinical findings.

Preventive Colorectal Surgery: Colectomy may be considered when the number, size, or distribution of polyps makes endoscopic management inadequate, or when colorectal cancer or significant symptoms are present.

Colectomy with Ileorectal Anastomosis: In selected patients, the colon may be removed while preserving the rectum, with the small intestine connected to the remaining rectum. Continued endoscopic surveillance of the rectum is required after surgery.

Proctocolectomy with Ileal Pouch-Anal Anastomosis: When there is extensive rectal polyposis, removal of both the colon and rectum may be considered, with creation of an ileal pouch to maintain bowel continuity.

Management of Upper Gastrointestinal and Other Manifestations: Upper GI endoscopy can identify gastric, duodenal, or periampullary adenomas. Selected lesions may be removed endoscopically, while thyroid or other abnormalities may require specialist evaluation.

  • Clinical assessment:
    • Colonoscopy and Polyp Evaluation: Colonoscopy helps identify and assess colorectal polyps based on their number, size, location, and appearance. Clinicians may excise suspicious or removable polyps for further evaluation.
    • Histopathology and Genetic Testing: Doctors examine removed polyps under a microscope to confirm their type. Germline MUTYH genetic testing can confirm MAP, and multigene panels may be considered when other hereditary syndromes are suspected.
    • Personal and Family History: Doctors review the patient's history of colorectal polyps or cancer and assess family history for hereditary colorectal conditions. This helps determine whether genetic counselling and family testing are needed.
    • Blood Tests and Upper GI Evaluation: A complete blood count and iron studies may identify anemia caused by gastrointestinal blood loss. Upper gastrointestinal endoscopy can assess the stomach, duodenum, and ampulla for associated polyps.
    • Genetic Counselling and Family Assessment: Genetic counselling helps patients understand MAP, its autosomal recessive inheritance, and implications for relatives. At-risk family members may be offered genetic testing and appropriate surveillance.
  • Imaging Tests:
    • Thyroid ultrasound: May be considered to evaluate or monitor thyroid abnormalities.
    • CT or MRI: May be used when complications, colorectal cancer, or other associated tumors require further assessment.
    • CT or MRI of the abdomen and pelvis: May be performed for staging when colorectal cancer is diagnosed.
    • Other targeted imaging: May be recommended when symptoms or examination findings suggest disease outside the gastrointestinal tract.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support MUTYH-Associated Polyposis patients in India. These services include:

  • Postoperative rehabilitation: Gradual physical activity and recovery support after abdominal or colorectal surgery.
  • Nutritional support: Dietary guidance following colectomy or other gastrointestinal procedures.
  • Bowel-function management: Education and support for changes in bowel habits following colorectal surgery.
  • Cancer rehabilitation: Exercise, nutrition, fatigue management, and psychological support when colorectal cancer treatment is required.
  • There is no medicine that corrects the inherited MUTYH variants or completely eliminates the need for colorectal surveillance. Medicines may also be used to manage symptoms, iron-deficiency anemia, postoperative complications, or colorectal cancer when present. Any chemoprevention or cancer-directed treatment should be selected by a specialist according to the patient's individual risk and clinical findings.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for MUTYH-Associated Polyposis in India

Gleneagles Hospital Mumbai: Top Doctors, and Reviews
Gleneagles Hospital Mumbai

Mumbai, India

  • Gleneagles Hospital, Parel, Mumbai, is a premier quaternary-care multispeciality hospital and a top destination for complex medical care in Western India.
  • Renowned for multi-organ transplants and advanced surgeries, the hospital offers specialised treatment across Cardiology, Neurology, Gastroenterology, Hepatology, Nephrology, Urology, Orthopaedics, Critical Care, Interventional Radiology, Gynaecology, and General Medicine.
  • Equipped with state-of-the-art diagnostic and surgical technology, including 3-Tesla MRI, 128-slice CT Scan, Bi-plane Cath Lab, and robotic surgery systems, Gleneagles provides integrated, patient-focused care.
  • Its expert team of doctors, nurses, and support staff ensures high standards of safety, efficiency, and compassionate care, making it a trusted healthcare destination for patients in Mumbai and beyond.
Message Us

291

PROCEDURE

16

SPECIALITIES

18+

FACILITIES & AMENITIES

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose India for MUTYH-Associated Polyposis Treatment?

  • Experienced Gastrointestinal Specialists: India has gastroenterologists, colorectal surgeons, genetic specialists, oncologists, pathologists, and other professionals who can help manage hereditary colorectal polyposis.
  • Advanced Endoscopic and Diagnostic Facilities: Specialised centres may provide high-quality colonoscopy, advanced polyp removal, upper GI endoscopy, genetic testing, pathology, and imaging for comprehensive disease assessment.
  • Minimally Invasive Colorectal Surgery: Patients requiring surgery may have access to laparoscopic and robotic colorectal procedures, depending on their clinical condition and the expertise available at the selected centre.
  • Multidisciplinary Cancer and Genetic Care: Patients can receive coordinated care involving gastroenterology, colorectal surgery, genetics, oncology, radiology, pathology, nutrition, and other specialities, as needed.
  • International Patient Support: Many major Indian hospitals provide international patient services that can assist with specialist consultations, diagnostic coordination, treatment planning, accommodation, travel arrangements, and postoperative follow-up.

Frequently Asked Questions

MAP is a lifelong inherited condition rather than a disease with a single recovery period. Recovery depends on the treatment received; recovery after colonoscopy is usually short, while colorectal surgery may take several weeks, followed by ongoing bowel and nutritional adjustment.

Yes. MAP itself does not usually prevent walking or routine physical activity. After colorectal surgery, increase activity gradually according to the surgeon's recommendations and the patient's recovery.

Many specialised Indian hospitals provide advanced colonoscopy, upper GI endoscopy, genetic testing, pathology, imaging, laparoscopic surgery, and robotic colorectal surgery. Specific facilities vary by hospital.

Many major Indian hospitals have international patient departments that can assist with medical consultations, treatment coordination, travel documentation, accommodation, transportation, interpretation, and follow-up planning.

Look for a centre experienced in hereditary colorectal cancer syndromes, advanced gastrointestinal endoscopy, colorectal surgery, genetic counselling, and long-term surveillance. Select the appropriate specialist team based on the patient's polyp burden, genetic findings, and treatment needs.

There is no single success rate for MAP because it is a lifelong genetic condition and outcomes depend on polyp burden, cancer status, treatment type, and long-term surveillance. Regular surveillance and timely management can substantially reduce the risk of complications from colorectal polyposis.

Specialised Indian centres may have gastroenterologists, colorectal surgeons, genetic specialists, oncologists, and other professionals experienced in managing hereditary colorectal conditions. Patients should consider the team's experience with MAP and related hereditary polyposis syndromes.

Risks depend on the treatment. Colonoscopy and polypectomy can rarely cause bleeding or perforation, while colorectal surgery may involve infection, bleeding, bowel-function changes, nutritional issues, anastomotic complications, or temporary or permanent ileostomy. Discuss individual risks with the treating specialist.

Consult a gastroenterologist and genetic specialist to confirm the diagnosis and assess the extent of polyposis. Important next steps include genetic counselling, colonoscopic evaluation, appropriate upper GI assessment, and developing a long-term surveillance plan.

MAP does not typically cause physical deformities. However, colorectal surgery may result in changes in bowel function or the need for an ileostomy, while associated cancers or other manifestations can affect physical health. Appropriate treatment and rehabilitation can help manage these effects.

Yes. Lifelong endoscopic surveillance, genetic testing, colorectal surgery, dietary changes, altered bowel function, or cancer treatment can affect quality of life. Psychological counselling, nutritional support, and appropriate follow-up can help patients manage these challenges.

Yes. Without appropriate surveillance, individuals with MAP have a substantially increased risk of colorectal cancer. MAP can also be associated with duodenal and other malignancies, making long-term surveillance and timely treatment important.

You cannot prevent this inherited genetic condition after a person inherits pathogenic variants in both copies of the MUTYH gene. However, complications can often be reduced through genetic counselling, testing of at-risk relatives, regular colonoscopy, removal of precancerous polyps, and timely surgery when indicated.

MAP can affect both males and females and is inherited in an autosomal recessive pattern. It is more likely in individuals who inherit a pathogenic MUTYH variant from both parents or who have a family history compatible with recessive inheritance. Genetic testing can identify affected individuals and carriers within families.